Quantcast

Latest pharmaceutical Stories

2014-10-01 08:31:09

SHANGHAI, Oct. 1, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (WuXi) (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, announced today that it has acquired XenoBiotic Laboratories, Inc. (XBL), a contract research organization with 27 years of successful operation that provides bioanalytical, drug metabolism, and pharmacokinetic services to the pharmaceutical,...

2014-09-30 23:10:20

ReportsnReports.com adds “Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, and Reverse Osmosis), Product (Filter Assembly, Filter Media), Accessories (Dispenser, Seal, Filter Flask, Vacuum Pump) & by End-User - Global Forecasts to 2019" global research report to its store. (PRWEB) September 30, 2014 Over the last decade, the laboratory filtration market is experiencing growth primarily due to rising R&D budgets and increased acceptance of new...

2014-09-29 08:30:12

A single ILUVIEN implant provides treatment for three years ATLANTA, Sept. 29, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will hold a conference call to provide additional information regarding the recent approval by the U.S. Food and Drug Administration (FDA) of ILUVIEN(®) for the treatment of...

2014-09-28 23:02:30

DotComWebDesign Announces New Pharmaceutical Marketing Services (PRWEB) September 28, 2014 DotComWebDesign, the premier digital marketing agency, is pleased to announce the addition of Pharmaceutical marketing services to its wide array of diverse services. With experience doing B2C marketing, DotcomWebDesign can help pharmaceutical companies connect with their target audience. Using a variety of mediums, ranging from traditional advertising, to more complicated mediums such as social...

2014-09-28 23:02:29

DotComWebDesign Announces New Mobile Marketing Service For Pharmaceutical Companies (PRWEB) September 28, 2014 DotComWebDesign, the premier pharmaceutical marketing company, is pleased to announce the addition of mobile marketing to its wide array of services geared towards practicing pharmaceutical companies. By leveraging this new service, Pharmaceutical companies can now engage with consumers through mobile devices. Services now offered include: mobile website design, mobile app...

2014-09-27 23:00:11

DotComWebDesign Announces New Pharmaceutical Strategy And Planning Services (PRWEB) September 28, 2014 DotComWebDesign, the premier pharmaceutical marketing agency, is pleased to announce the addition of strategy and planning services to its wide array of services geared towards pharmaceutical companies. Prospective pharmaceutical companies interested in learning more about the plethora of pharmaceutical marketing services available by DotComWebDesign, are encouraged to visit the strategy...

2014-09-16 23:13:20

InTouchMD™ launches innovative social media tool that allows pharmaceutical companies and physicians to better connect with their patients. Garden City, NY (PRWEB) September 16, 2014 InTouchMD, a New York based multi-channel contact center dedicated to serving the healthcare industry, has launched a revolutionary service that gives pharmaceutical companies the ability to connect to their patients through social media in order to foster better patient diagnostics and care. “We have...

2014-09-16 08:29:41

Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus® and its insulin analog to Sanofi's Lantus®. http://photos.prnewswire.com/prnvar/20140423/77793 In October 2014, Mylan will commence a Phase III...

2014-09-16 04:21:18

WHIPPANY, N.J., Sept. 16, 2014 /PRNewswire/ -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. The study, called ARAMIS, evaluates ODM-201 in men with castration-resistant prostate cancer who have rising Prostate Specific Antigen (PSA) levels and no detectable metastases. The trial is designed to...

2014-09-09 12:29:19

MENLO PARK, Calif., Sept. 9, 2014 /PRNewswire/ -- SRI International, an independent nonprofit research institute, and Nobelpharma, a Japanese pharmaceutical company, have entered into a licensing agreement to test SR16234, an SRI drug candidate that may be effective in treating endometriosis. SR16234 is a member of a class of drugs known as selective estrogen receptor modulators (SERMs) that regulate the effects of the hormone estrogen. "This important collaboration is addressing a...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related